Restless Legs Syndrome
📧 Sign up to get email alerts when something new happens for Restless Legs Syndrome.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2024-03-11EMA Withdrawn: Pramipexole Accord (pramipexole dihydrochloride monohydrate) — Accord Healthcare S.L.U.
Withdrawn EMA decision for Pramipexole Accord (pramipexole dihydrochloride monohydrate) by Accord Healthcare S.L.U., affecting Parkinson's d…
-
CLINICAL_TRIALS withdrawal · 2023-10-25Clinical Trial Update: Butrans for Treatment of Restless Legs Syndrome [Phase 4]
Phase 4 clinical trial of Butrans for restless legs syndrome has been withdrawn.
-
EMA withdrawal · 2022-02-18EMA Withdrawn: Leganto (rotigotine) — UCB Pharma S.A.
Leganto (rotigotine) has been withdrawn from the market by UCB Pharma S.A., affecting treatment areas including restless legs syndrome and P…
-
CLINICAL_TRIALS withdrawal · 2021-11-16Clinical Trial Update: Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome [Phase 4]
A Phase 4 trial of pregabalin for Restless Legs Syndrome was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-01-22Clinical Trial Update: 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects [Phase 3]
A Phase 3 trial evaluating pregabalin for Restless Legs Syndrome was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2018-07-11EMA Application withdrawn: Rotigotine Mylan (rotigotine) — Mylan S.A.S
The EMA has withdrawn the marketing authorization application for Rotigotine Mylan (rotigotine) submitted by Mylan S.A.S, for restless legs …
-
CLINICAL_TRIALS withdrawal · 2015-06-30Clinical Trial Update: IV Iron Treatment of Restless Legs Syndrome [Phase 2]
A Phase 2 clinical trial evaluating intravenous iron for restless legs syndrome was withdrawn; no results are reported.
-
CLINICAL_TRIALS withdrawal · 2015-06-16Clinical Trial Update: Vasculaire Leg Compression Device for the Treatment of Restless Legs Syndrome - A Prospective Clinical Study [NA]
A prospective clinical study evaluating a vascular leg compression device for restless legs syndrome has been withdrawn.
-
EMA withdrawal · 2009-12-03EMA Application withdrawn: Nenad (lisuride) — Axxonis Pharma AG
The EMA application for Nenad (lisuride) by Axxonis Pharma AG has been withdrawn for Restless Legs Syndrome.